Pathological Conditions, Signs and Symptoms: News and Research on Shock

MeSH tree: C23.550.835

New therapeutic target expands options for multiple myeloma

In a phase 1 clinical trial, treatment with the investigational bispecific antibody cevostamab reduced cancer in more than 40% of patients with multiple myeloma, many of whom had already undergone multiple other cancer treatments, ...

page 1 from 21